Why Do Integrated Services Matter?
From discovery to intermediates, APIs & drug products, a CDMO needs expertise across multiple elements of the pharma process to deliver an integrated experience
Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.Tim Wright, Editor, Contract Pharma 04.07.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, Takeda Enter Multi-RNA Target Alliance
To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.Kristin Brooks 03.22.21
-
Bio News | Breaking News | Collaborations & Alliances | CRO News | Drug Development | Drug Discovery | Industry News | R&D
Innoforce and dMed Enter Development Collaboration
Aims to accelerate the development of innovative therapeutics.Tim Wright, Editor, Contract Pharma 03.03.21
-
Breaking News | CRO News | Drug Discovery | Industry News | R&D
Icon to Acquire PRA Health Sciences
Brings together two organizations to create a leading healthcare intelligence and clinical CRO.Charles Sternberg, Assistant Editor 03.01.21
-
Analytical Services | Breaking News | Drug Discovery | Facilities | Industry News | R&D
CatSci Opens New Site in UK
Strengthens analytical capabilities with the opening of a secondary site in Dagenham backed by a $4.2 million investment.Tim Wright, Editor, Contract Pharma 02.25.21
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
CrownBio & JSR Life Sciences Partner with Cambridge Quantum Computing
Will leverage quantum machine learning for novel cancer treatment biomarker discovery.Tim Wright, Editor, Contract Pharma 02.25.21
-
Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
Jubilant Biosys, Yale Form Research Alliance
Aims to accelerate small molecule discovery programs leveraging Jubilant's medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology.02.10.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Evozyne, Takeda Ink Strategic Protein Design Agreement
Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.Kristin Brooks 01.28.21
-
Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
X-Chem Acquires IntelliSyn and AviSyn
Acquisitions allow the company to offer services for screening, hit validation and lead optimization on existing and new markets.Kristin Brooks 01.26.21
-
Breaking News | Drug Development | Drug Discovery | Industry News
Lilly Completes $1B Acquisition of Prevail
Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.Kristin Brooks 01.22.21
-
Breaking News | Collaborations & Alliances | Drug Discovery
Metrion, LifeArc Extend Neuroscience Alliance
Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.Contract Pharma Staff 01.18.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Janssen, TenNor Enter NTM Research Pact
To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.Contract Pharma Staff 01.18.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
EVOQ Therapeutics and Amgen Partner
Collaborate on the discovery and development of novel drugs for autoimmune disorders.Contract Pharma Staff 01.13.21
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Almac Sciences Secures Support from Invest NI
Accelerates enzyme discovery program.Contract Pharma Staff 01.13.21
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Mogrify Enters Research Collaboration with MRC LMB
Research project aims to develop novel protein expression systems via cell reprogramming.Contract Pharma Staff 01.11.21
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Servier and X-Chem Enter Drug Discovery Collaboration
Partner to identify and develop novel small molecules for the treatment of neurological disorders.Contract Pharma Staff 01.07.21
-
Breaking News | CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Labs Acquires Distributed Bio
Establishes integrated, large molecule discovery platform.Contract Pharma Staff 01.04.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, BMS Advance Targeted Protein Degradation Projects
The first two targets transition into drug discovery after completing a comprehensive target validation process.Contract Pharma Staff 12.17.20
-
Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
Evotec and Sartorius Partner with Curexsys
Leverage IPSC platform for scalable manufacturing of Curexsys' exosome-based therapeutics.Contract Pharma Staff 12.09.20
-
APIs | Drug Development | Drug Discovery
